NCT07094815

Brief Summary

This study aims to compare the effectiveness of laparoscopic lateral suspension (LLS) with and without hysterectomy in the treatment of pelvic organ prolapse. Pelvic organ prolapse is a condition that affects many women and can significantly reduce quality of life. Laparoscopic lateral suspension is a minimally invasive surgical technique used to correct this condition. In some cases, the uterus is preserved, while in others, hysterectomy is performed at the same time. The study retrospectively evaluates patients who underwent laparoscopic lateral suspension, either with or without hysterectomy, at SBÜ Gaziosmanpaşa Training and Research Hospital. Medical records were reviewed to collect information about surgery duration, anatomical success (measured by the POP-Q system), complication rates, blood loss, hospital stay, and recurrence rates. The goal of this study is to determine whether performing a hysterectomy during laparoscopic lateral suspension has a significant effect on surgical outcomes. The findings may help guide surgical decision-making and improve treatment strategies for women with pelvic organ prolapse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 28, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2025

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

July 23, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 30, 2025

Completed
Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

July 23, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

Laparoscopic Lateral SuspensionUterus PreservationUterine ProlapsePelvic Organ ProlapseMinimally Invasive SurgeryPOP-Q SystemSurgical OutcomesGynecologic SurgeryPelvic Floor Disorders

Outcome Measures

Primary Outcomes (1)

  • Anatomical Success Based on POP-Q System

    Primary Outcome Title: Number of Participants Achieving Anatomical Success Based on POP-Q System Description: Anatomical success is defined as all assessed POP-Q points (Aa, Ba, C, D, Ap, Bp) being at or above -1 cm (no prolapse extending more than 1 cm below the hymen). POP-Q scale values: Negative values indicate the point is above the hymen (better anatomy), positive values indicate prolapse below the hymen (worse anatomy). Typical range: Aa, Ba, Ap, Bp = -3 to +3 cm; C and D vary according to total vaginal length (TVL). Time Frame: 12 months after surgery

    12 months after surgery

Study Arms (2)

LLS with Hysterectomy

Patients who underwent laparoscopic lateral suspension combined with total laparoscopic hysterectomy.

Uterus-Preserving LLS

Patients who underwent laparoscopic lateral suspension with uterine preservation.

Eligibility Criteria

Age40 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female patients aged 40 to 80 years who underwent laparoscopic lateral suspension (LLS) with or without concomitant total laparoscopic hysterectomy for the treatment of pelvic organ prolapse at SBÜ Gaziosmanpaşa Training and Research Hospital between 2021 and 2024. All patients had at least 12 months of postoperative follow-up, and data were collected retrospectively from medical records.

You may qualify if:

  • Female patients aged 40 to 80 years
  • Diagnosis of pelvic organ prolapse (POP) requiring surgical management
  • Underwent laparoscopic lateral suspension (LLS) with or without concomitant total laparoscopic hysterectomy
  • Minimum of 12 months postoperative follow-up available
  • Ability to provide informed consent for use of medical data in this retrospective study

You may not qualify if:

  • History of connective tissue disorders
  • History of prior pelvic reconstructive surgery
  • Active pelvic infection or suspected malignancy at the time of surgery
  • Severe systemic disease that could significantly affect surgical outcomes
  • Incomplete medical records or missing follow-up data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Gaziosmanpaşa Training and Research Hospital

Istanbul, Istanbul, 34255, Turkey (Türkiye)

Location

Related Publications (1)

  • Kumbasar S, Salman S, Sogut O, K Gencer F, Bacak HB, Tezcan AD, Timur GY. Uterine-sparing laparoscopic lateral suspension in the treatment of pelvic organ prolapse. J Obstet Gynaecol Res. 2023 Jan;49(1):341-349. doi: 10.1111/jog.15459. Epub 2022 Oct 5.

    PMID: 36196844BACKGROUND

MeSH Terms

Conditions

Pelvic Organ ProlapseUterine ProlapsePelvic Floor Disorders

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
M.D

Study Record Dates

First Submitted

July 23, 2025

First Posted

July 30, 2025

Study Start

May 28, 2025

Primary Completion

June 28, 2025

Study Completion

June 28, 2025

Last Updated

August 6, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because this study is based on retrospective medical record review and no consent for data sharing was obtained from participants. All data are stored and analyzed internally according to institutional policies and ethical approvals.

Locations